When it comes to bone health the choice is simple


Accrete-D3


is the least expensive calcium & vitamin D3


combination


that offers a choice of presentation for the patient and prescriber.1 Rx Accrete-D3 by brand and save up to 24% vs. the market leading brand.1


Accrete D3 One-a-Day 1000 mg/880 IU Chewable Tablets® & Accrete D3 Film-Coated Tablets®


Information: Please refer to the appropriate Summary of Product Characteristics (SmPC) before prescribing Accrete D3


One-a-Day 1000 mg/880 IU Chewable Tablets® Tablets® : Each chewable


Abbreviated Prescribing . Accrete D3


tablet contains 1000 mg calcium (as 2500 mg calcium carbonate) and 880 IU colecalciferol. Contains aspartame (E951), sorbitol (E420), isomalt (E953) and sucrose. Accrete D3


Film-Coated : Contains 600 mg calcium (as calcium carbonate 1500


mg) and 10 micrograms of colecalciferol (equivalent to 400 IU vitamin D3) and sucrose. Indication: Prevention and treatment of vitamin D and calcium deficiency in the elderly. Adjunct to specific osteoporosis treatment of patients at risk of vitamin D and calcium


One tablet twice per day. Contraindications: Hypersensitivity to any of the ingredients, hypercalciuria/hypercalcaemia and conditions leading to hypercalciuria/hypercalcaemia, nephrolithiasis, nephrocalcinosis, hypervitaminosis D, severe renal impairment/ renal failure. Not for paediatric use. Warnings and Precautions: Monitor serum calcium and creatinine (renal function) in cases of long-term use, concomitant use of cardiac glycosides or thiazide diuretics, or a high tendency to calculus


deficiency. Dosage and Administration: For oral use. Accrete D3 One-a-Day: One chewable tablet daily. Accrete D3


Film-Coated:


least 3 hours before Accrete D3. Do not use levothyroxine within 4 hours before or after Accrete D3. Administer quinolone antibiotics <2 hours before or 6 hours after Accrete D3. Pregnancy and


formation. Use caution and monitor calcium and phosphate in cases of renal impairment. In cases of hypercalcaemia or impaired renal function, reduce the dose or discontinue treatment. Use caution in cases of sarcoidosis, immobilised patients with osteoporosis. In patients with a history of renal stones, hypercalciuria should be excluded. Use close medical supervision if prescribing additional calcium or vitamin D via other medicines. Concomitant use of tetracyclines or quinolones is not recommended. Do not take in case of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency. This medicinal product contains aspartame (E951), a source of phenylalanine which may be harmful for people with phenylketonuria. Interactions: Thiazide diuretics, cardiac glycosides, systemic corticosteroids, phenytoin, barbituates, ion exchange resins, laxatives. Do not take calcium within 2 hours of eating foods high in oxalic acid and phytic acid. Administer tetracycline <2 hours before or 4 to 6 hours after Accrete D3


. Administer bisphosphonate or sodium fluoride at


Lactation: During pregnancy, daily dose should not exceed 1500 mg calcium and 600 IU vitamin D. Halve tablet if necessary to reduce dose. Suitable for use during breastfeeding. Calcium and


30 tablets; Accrete D3 Film-Coated: £2.95 for 60 tablets. MA Number: Accrete D3 One-a-Day: PL04416/1318; Accrete D3


vitamin D pass into breast milk. This should be considered when giving additional vitamin D to the child. Undesirable effects: Allergic reactions may be possible. Uncommonly hypercalcaemia or hypercalciuria. Rarely gastro-intestinal disorders, rash, pruritus, urticaria. Legal Category: Accrete D3 D3 Film-Coated: P. Pack size: Accrete D3


Film-Coated): Internis Pharmaceuticals Ltd.,


One-a-Day: P; Accrete One-a-Day: £2.95 for


Film-


Linthwaite Laboratories, Linthwaite, Huddersfield, HD7 5QH, UK. Date of preparation: November 2017. Unique ID: ACC-0101.


Coated: PL 40861/0001 Distributor (Accrete One-a-Day)/MA Holder (Accrete D3


Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported on 01484 848164.


Reference: 1. NHS list price data, MIMS - accessed January 2018. Date of preparation: February 2018. ACC-107.


O N E D A Y


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64